Reactions Weekly

, Volume 1695, Issue 1, pp 102–102 | Cite as

Chlorambucil/obinutuzumab

Severe and prolong haematologic toxicity: case report
Case report
First Online:
  • 25 Downloads
This is a preview of subscription content, log in to check access

Reference

  1. Fogliatto L, et al. Obinutuzumab for CLL relapsed and refractory patients when new oral drugs an not available. Blood 130: 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/5341?sso-checked=true [abstract] - Brazil

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Personalised recommendations